Ted Trimble

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Intraperitoneal chemotherapy and the NCI clinical announcement
    Edward L Trimble
    Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 02138, USA
    Gynecol Oncol 103:S18-9. 2006
  2. ncbi request reprint Untreated cervical cancer in the United States
    Edward L Trimble
    Surgery Section, National Cancer Institute, 6130 Executive Boulevard, Suite 741, MSC 7436, Bethesda, MD 20892 7436, USA
    Gynecol Oncol 96:271-7. 2005
  3. ncbi request reprint Pre-operative imaging, surgery and adjuvant therapy for women diagnosed with cancer of the corpus uteri in community practice in the United States
    Edward L Trimble
    National Cancer Institute, Surgery Section, 6130 Executive Boulevard, Ste 741, M, Bethesda, MD 20892 7436, USA
    Gynecol Oncol 96:741-8. 2005
  4. ncbi request reprint Cervical cancer state-of-the-clinical-science meeting on pretreatment evaluation and prognostic factors, September 27-28, 2007: proceedings and recommendations
    Edward L Trimble
    National Cancer Institute, Bethesda, MD 20892 7436, USA
    Gynecol Oncol 114:145-50. 2009
  5. doi request reprint National Cancer Institute-United States strategy regarding intraperitoneal chemotherapy for ovarian cancer
    E L Trimble
    Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892 7436, USA
    Int J Gynecol Cancer 18:26-8. 2008
  6. pmc Improving cancer outcomes through international collaboration in academic cancer treatment trials
    Edward L Trimble
    National Cancer Institute, Bethesda, MD 20892 7436, USA
    J Clin Oncol 27:5109-14. 2009
  7. ncbi request reprint Grants, clinical trials, and building research teams
    Edward L Trimble
    Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD 20892, USA
    Gynecol Oncol 99:S6. 2005
  8. ncbi request reprint Global strategies for cervical cancer control in the 21st century
    Ted Trimble
    National Cancer Institute, 6130 Executive Blvd, Suite 741, MSC 7436, Bethesda, MD 20892 7436, USA
    Gynecol Oncol 99:S245. 2005
  9. ncbi request reprint Summary and discussion of session recommendations
    Jane Fountain
    National Cancer Institute, Bethesda, MD 20892, USA
    Gynecol Oncol 103:S23-5. 2006
  10. ncbi request reprint Treatment of platinum-resistant ovarian cancer
    E L Trimble
    Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA
    Expert Opin Pharmacother 2:1299-306. 2001

Detail Information

Publications50

  1. ncbi request reprint Intraperitoneal chemotherapy and the NCI clinical announcement
    Edward L Trimble
    Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 02138, USA
    Gynecol Oncol 103:S18-9. 2006
  2. ncbi request reprint Untreated cervical cancer in the United States
    Edward L Trimble
    Surgery Section, National Cancer Institute, 6130 Executive Boulevard, Suite 741, MSC 7436, Bethesda, MD 20892 7436, USA
    Gynecol Oncol 96:271-7. 2005
    ..To evaluate treatment patterns, including lack of treatment, among women diagnosed with cervical cancer in the United States...
  3. ncbi request reprint Pre-operative imaging, surgery and adjuvant therapy for women diagnosed with cancer of the corpus uteri in community practice in the United States
    Edward L Trimble
    National Cancer Institute, Surgery Section, 6130 Executive Boulevard, Ste 741, M, Bethesda, MD 20892 7436, USA
    Gynecol Oncol 96:741-8. 2005
    ..Non-Hispanic black women are less often diagnosed with endometrial cancer than are non-Hispanic white women, but are more likely to die of their disease. Reasons for this disparity in outcome are not well understood...
  4. ncbi request reprint Cervical cancer state-of-the-clinical-science meeting on pretreatment evaluation and prognostic factors, September 27-28, 2007: proceedings and recommendations
    Edward L Trimble
    National Cancer Institute, Bethesda, MD 20892 7436, USA
    Gynecol Oncol 114:145-50. 2009
    ..We choose to review current knowledge focused on pretreatment evaluation and prognostic markers in cervical cancer and make recommendations for future research...
  5. doi request reprint National Cancer Institute-United States strategy regarding intraperitoneal chemotherapy for ovarian cancer
    E L Trimble
    Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892 7436, USA
    Int J Gynecol Cancer 18:26-8. 2008
    ..The further development of IP chemotherapy in ovarian cancer requires additional clinical and translational research...
  6. pmc Improving cancer outcomes through international collaboration in academic cancer treatment trials
    Edward L Trimble
    National Cancer Institute, Bethesda, MD 20892 7436, USA
    J Clin Oncol 27:5109-14. 2009
    ..We sought to identify those efforts already underway which facilitate such collaboration, as well as barriers to greater collaboration...
  7. ncbi request reprint Grants, clinical trials, and building research teams
    Edward L Trimble
    Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD 20892, USA
    Gynecol Oncol 99:S6. 2005
  8. ncbi request reprint Global strategies for cervical cancer control in the 21st century
    Ted Trimble
    National Cancer Institute, 6130 Executive Blvd, Suite 741, MSC 7436, Bethesda, MD 20892 7436, USA
    Gynecol Oncol 99:S245. 2005
  9. ncbi request reprint Summary and discussion of session recommendations
    Jane Fountain
    National Cancer Institute, Bethesda, MD 20892, USA
    Gynecol Oncol 103:S23-5. 2006
  10. ncbi request reprint Treatment of platinum-resistant ovarian cancer
    E L Trimble
    Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA
    Expert Opin Pharmacother 2:1299-306. 2001
    ..The 5 year survival for women with stage III disease is 15-30% and 0-20% for those with stage IV disease. Medical and gynecological oncologists, therefore, must be prepared to treat many women with recurrent ovarian cancer...
  11. ncbi request reprint Concluding remarks: optimal treatment for women with ovarian cancer
    Edward L Trimble
    National Cancer Institute, Bethesda, MD 20892 7436, USA
    Semin Oncol 33:S25-6. 2006
  12. pmc Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009
    Edward L Trimble
    National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7436, USA
    Int J Gynecol Cancer 20:1290-8. 2010
    ..To review the current status of large phase academic clinical trials for women with ovarian cancer, address cross-cutting issues, and identify promising areas for future collaboration...
  13. pmc Patterns of care for women with cervical cancer in the United States
    Edward L Trimble
    National Cancer Institute, Surgery Section, Bethesda, Maryland 20892 7436, USA
    Cancer 113:743-9. 2008
    ..This analysis was initiated to determine any systemic changes in management of cervical cancers...
  14. doi request reprint Intraperitoneal chemotherapy for women with epithelial ovarian cancer
    Edward L Trimble
    Division of Cancer Treatment and Diagnosis, National Cancer Institute, 6130 Executive Boulevard, Suite 7025, MSC 7436, Bethesda, Maryland 20892 7436, USA
    Oncologist 13:403-9. 2008
    ..p. chemotherapy, the data supporting its use, the selection of appropriate patients for i.p. chemotherapy, how best to avoid and manage the toxicities observed with i.p. chemotherapy, and directions for future research...
  15. ncbi request reprint Clinical trials referral resource. Clinical trials in ovarian cancer, Part 2
    Edward L Trimble
    National Cancer Institute, Bethesda, MD, USA
    Oncology (Williston Park) 16:1660-2, 1665-7. 2002
  16. ncbi request reprint Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States
    Linda C Harlan
    National Cancer Institute, 6130 Executive Blvd, MSC 7344, Bethesda, MD 20892 7344, USA
    J Clin Oncol 21:3488-94. 2003
    ..We examined patterns of care in a population-based sample of 601 ovarian cancer patients diagnosed in 1991, and a sample of 566 women was selected in 1996 to examine trends in care...
  17. ncbi request reprint Clinical Trials Referral Resource. Clinical trials in cervical cancer
    Edward L Trimble
    National Cancer Institute, Bethesda, MD, USA
    Oncology (Williston Park) 17:84-9. 2003
  18. ncbi request reprint Treatment and survival for women with Fallopian tube carcinoma: a population-based study
    Carol Kosary
    National Cancer Institute, Bethesda, Maryland 20892, USA
    Gynecol Oncol 86:190-1. 2002
    ..The objective of this study was to evaluate treatment and survival for women with fallopian tube carcinoma in a population-based data set...
  19. ncbi request reprint Clinical trials referral resource. Clinical trials in ovarian cancer; Part 1
    Edward L Trimble
    National Cancer Institute, Bethesda, MD, USA
    Oncology (Williston Park) 16:1498-9, 1504, 1506-7. 2002
  20. ncbi request reprint Clinical trials referral resource. Current clinical trials investigating cancer in the elderly
    Edward L Trimble
    National Cancer Institute, Bethesda, MD, USA
    Oncology (Williston Park) 17:1712-3, 1718-9. 2003
  21. ncbi request reprint Long-term survival and patterns of care in women with ovarian tumors of low malignant potential
    Cornelia Liu Trimble
    Department of Gynecology and Obstetrics, The Johns Hopkins Hospital, Baltimore, Maryland, USA
    Gynecol Oncol 86:34-7. 2002
    ..The objectives of this study were to ascertain long-term survival and patterns of care among women diagnosed with ovarian tumors of low malignant potential (LMP) in a population-based data set...
  22. ncbi request reprint Clinical trials referral resource. Current treatment trials for epithelial ovarian cancer
    Edward L Trimble
    National Cancer Institute, Bethesda, USA
    Oncology (Williston Park) 19:897-8, 900, 905-6 passim. 2005
  23. doi request reprint NIH and NCI support for development of novel therapeutics in gynecologic cancer: a user's guide
    Lucas Minig
    National Cancer Institute, Bethesda, MD 20892, USA
    Gynecol Oncol 116:177-80. 2010
    ..Finally, the NIH and the NCI sponsor a variety of grant mechanisms, supporting institutions, consortia, and individuals, which investigators seeking to develop novel therapeutics should make themselves familiar...
  24. ncbi request reprint Current clinical trials of HPV vaccines
    Edward L Trimble
    National Cancer Institute, Bethesda, MD, USA
    Oncology (Williston Park) 18:859-60, 862. 2004
  25. ncbi request reprint Ovarian tumors of low malignant potential
    Cornelia Liu Trimble
    Departments of Gynecology, Obstetrics, and Oncology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Oncology (Williston Park) 17:1563-7; discussion 1567-70, 1575. 2003
    ....
  26. ncbi request reprint Clinical trials in gynecological cancer
    E L Trimble
    National Cancer Institute Cancer Therapy Evaluation Program, Bethesda, MD, USA
    Int J Gynecol Cancer 17:547-56. 2007
    ..Other critical issues include support from government and charities and government regulations...
  27. ncbi request reprint Increasing participation of physicians and patients from underrepresented racial and ethnic groups in National Cancer Institute-sponsored clinical trials
    Michaele C Christian
    Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA
    Cancer Epidemiol Biomarkers Prev 12:277s-283s. 2003
  28. ncbi request reprint Clinical trials referral resource. Current clinical trails in endometrial cancer
    Edward L Trimble
    National Cancer Institute, Bethesda, MD, USA
    Oncology (Williston Park) 17:238-40, 244, 249. 2003
  29. ncbi request reprint Health-related quality of life and symptom management research sponsored by the National Cancer Institute
    Lori M Minasian
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7340, USA
    J Clin Oncol 25:5128-32. 2007
    ..The scope of NCI's research in symptom management and HRQOL is described with attention to its evolution over time and the next steps, through the Clinical Trials Working Group Recommendations...
  30. ncbi request reprint Grantsmanship and career development for gynecologic cancer investigators
    Edward L Trimble
    Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA
    Cancer 98:2075-81. 2003
    ..Developing a successful academic career with a focus on research in gynecologic cancer requires planning and a supportive environment...
  31. ncbi request reprint Clinical trials referral source. Current randomized phase III trials in gynecologic cancer
    Edward L Trimble
    National Cancer Institute, Bethesda, MD, USA
    Oncology (Williston Park) 18:1642, 1645-6. 2004
  32. doi request reprint Building the evidence base for postoperative and postpartum advice
    Lucas Minig
    Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    Obstet Gynecol 114:892-900. 2009
    ..The evidence base informing advice for most of these issues is minimal; we need prospective, well-designed studies to help guide us and our patients...
  33. ncbi request reprint A pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer
    M A Steller
    Section of Gynecologic Oncology, Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Cancer Chemother Pharmacol 43:106-14. 1999
    ..Patients and..
  34. doi request reprint Integrating cancer control into global health
    Harold Varmus
    National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    Sci Transl Med 3:101cm28. 2011
    ..Here, we discuss ways in which the National Cancer Institute's newly formed Center for Global Health plans to stem the rising cancer burden in developing countries...
  35. ncbi request reprint Hormones and endometrial cancer--new data from the Million Women Study
    Louise A Brinton
    National Cancer Institute, Bethesda, MD 20892, USA
    Lancet 365:1517-8. 2005
  36. ncbi request reprint Patterns of care for women with ovarian cancer in the United States
    K A Munoz
    Division of Cancer Prevention and Control, and Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    J Clin Oncol 15:3408-15. 1997
    ..To characterize treatments for ovarian cancer, to determine if recommended staging and treatment were provided, and to determine factors that influence receipt of recommended staging and treatment...
  37. ncbi request reprint How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials
    Warren B Sateren
    Walter Reed Army Institute of Research, Rockville, MD, USA
    J Clin Oncol 20:2109-17. 2002
    ..We chose to examine the impact of socioeconomic factors on accrual to National Cancer Institute (NCI)-sponsored cancer treatment trials...
  38. ncbi request reprint Clinical trials referral resource. Current clinical trials of supportive care/palliative care
    Mason Schoenfeldt
    EMMES Corporation, Rockville, MD, USA
    Oncology (Williston Park) 17:1578, 1583-5, 1589-90. 2003
  39. ncbi request reprint Cancer of the uterine corpus among Hispanic women living in the United States: patterns of staging, diagnosis, and primary treatment
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 96:753-9. 2005
    ..To evaluate the demographic characteristics, clinico-pathological features, and patterns of care of uterine cancer among Hispanic women living in the United States...
  40. ncbi request reprint Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients
    Craig C Earle
    Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Natl Cancer Inst 98:172-80. 2006
    ..e., better outcomes). We examined associations between physician specialty and outcomes in a population-based cohort of elderly ovarian cancer surgery patients...
  41. ncbi request reprint Cancer treatment and the older patient
    Edward L Trimble
    Clin Cancer Res 12:1956-7. 2006
  42. ncbi request reprint Intraperitoneal chemotherapy for women with advanced epithelial ovarian carcinoma
    Edward L Trimble
    Gynecol Oncol 100:3-4. 2006
  43. ncbi request reprint Patterns of care for cervical cancer patients treated in the U.S. military health care system
    John H Farley
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Tripler Army Medical Center, Honolulu, HI 96859 5000, USA
    J Reprod Med 52:1040-5. 2007
    ..S. Department of Defense (DOD) Military Health Care System received treatment within standard guidelines and whether survival was influenced by implementation of these guidelines...
  44. ncbi request reprint Patient-reported outcomes assessment in cancer trials: taking stock, moving forward
    Joseph Lipscomb
    Emory University, Atlanta, GA 30322, USA
    J Clin Oncol 25:5133-40. 2007
    ....
  45. ncbi request reprint Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection
    Deborah Schrag
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Natl Cancer Inst 98:163-71. 2006
    ..e., hospital or surgeon) procedure volumes and patient outcomes have been demonstrated for many types of cancer operation. We performed a population-based cohort study to examine these associations for ovarian cancer resections...
  46. ncbi request reprint Practice patterns of radiotherapy in cervical cancer among member groups of the Gynecologic Cancer Intergroup (GCIG)
    David K Gaffney
    Radiation Therapy Oncology Group, Salt Lake City, UT 84112, USA
    Int J Radiat Oncol Biol Phys 68:485-90. 2007
    ..The aim of this study was to describe radiotherapeutic practice of the treatment of cervical cancer in member groups of the Gynecologic Cancer Intergroup (GCIG)...
  47. ncbi request reprint Ovarian cancer surgery in Maryland: volume-based access to care
    Robert E Bristow
    Department of Biostatistics, Johns Hopkins Oncology Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 93:353-60. 2004
    ..To characterize the patterns of primary surgical care for ovarian cancer in a statewide population according to annual surgeon and hospital case volume...
  48. ncbi request reprint Abdominal carcinomatosis in women with a history of breast cancer
    Ruchi Garg
    Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 N Wolfe Street, Baltimore, MD 21287 1281, USA
    Gynecol Oncol 99:65-70. 2005
    ....
  49. ncbi request reprint Participation of patients 65 years of age or older in cancer clinical trials
    Joy H Lewis
    RAND Health, Santa Monica, CA 90407 2138, USA
    J Clin Oncol 21:1383-9. 2003
    ..Our objective was to evaluate the participation of the elderly in clinical trials sponsored by the National Cancer Institute (NCI) and assess the impact of protocol exclusion criteria on elderly participation...
  50. ncbi request reprint Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis
    Robert E Bristow
    Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD 21287 1248, USA
    J Clin Oncol 20:1248-59. 2002
    ..To evaluate the relative effect of percent maximal cytoreductive surgery and other prognostic variables on survival among cohorts of patients with advanced-stage ovarian carcinoma treated with platinum-based chemotherapy...